A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.
Status:
Not yet recruiting
Trial end date:
2024-03-30
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of HR19042 capsules for the treatment of
autoimmune hepatitis. It will also explore the optimal frequency and dosage of HR19042
capsules administration for the treatment.